BioNano Genomics Inc vs First Solar, Inc. — how do they compare? BioNano Genomics Inc trades at $1.18 (market cap $13.77M), while First Solar, Inc. trades at $224.05 (market cap $25.89B). The key difference: First Solar, Inc. is far larger — about 1880.2× BioNano Genomics Inc's market cap, and First Solar, Inc. is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.
| BNGO | FSLR | |
|---|---|---|
Market Cap | $13.77M | $25.89B |
Sector | Health | Technology |
52-Week High | $4.92 | $318.30 |
52-Week Low | $1.06 | $180.05 |
Enterprise Value | $16.38M | $24.36B |
Trailing returns across standard periods
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →First Solar designs and manufactures solar photovoltaic panels, modules, and systems for use in utility-scale development projects. The company's solar modules use cadmium telluride to convert sunlight into electricity. This is commonly called thin-film technology. First Solar is the world's largest thin-film solar module manufacturer. It has production lines in Vietnam, Malaysia, the United States, and a new factory under construction in India.
Read more on FSLR →